Stock ORAMED PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Equities

US68403P1049

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Oramed Pharmaceuticals, Inc.
06-12 Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket MT
06-10 Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024 CI

Chart calendar Oramed Pharmaceuticals, Inc.

ba2066838b5cf8d63.MLGhgy8DG6vvRzCYxVGGeJYR2Z00KUuOt1K2a40z2pE.WMjo6UNFbO7bEwXznBDcEe5i4c9jBHnD8j7nUsVAtcdznM3zcDojwbt0cQ~7c547abec1e52fa6f84cbdc507a9c2b8

Upcoming events on Oramed Pharmaceuticals, Inc.

09/07/2024 Q3 2024 Earnings Release (Projected)

Past events on Oramed Pharmaceuticals, Inc.

13/07/2023 14:00 Annual General Meeting
23/06/2023 23:15 American Diabetes Association Scientific Session
31/05/2023 18:30 Novel Therapies for Diabetes & Obesity Summit
10/05/2023 Q1 2023 Earnings Release
07/12/2022 18:30 Planet MicroCap Showcase
17/11/2022 16:00 ORMD-0801 Phase 2 Trial Results Call
10/11/2022 21:30 Q3 2022 Earnings Release
13/09/2022 20:00 H.C. Wainwright Global Investment Conference
10/08/2022 21:30 Canaccord Growth Conference
30/06/2022 14:00 Annual General Meeting
25/05/2022 17:00 H.C. Wainwright Global Life Sciences Investment Conference
30/03/2022 17:00 Investor Meeting - Key Opinion Leader
15/03/2022 19:50 Barclays Global Healthcare Conference
24/02/2022 14:30 Aegis Capital Virtual Summit
04/01/2022 LifeSci Partners Corporate Access Event
24/11/2021 FY 2021 Earnings Release
18/11/2021 16:00 Oravax Medical Inc and Genomma Lab 50/50 Joint Venture Agreement Call
15/11/2021 16:30 H.C. Wainwright Israel Conference
30/09/2021 17:00 Cantor Fitzgerald Global Healthcare Conference
13/09/2021 12:00 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2,70
2,70
0.22%		2,71
3,96
-31.48%		0,90


2,70
2,76
-2.24%		1,34
1,32
1.52%
0,75

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-14,6
-16,7
12.58%		-11,8
-16,9
30.42%		0,00


-40,6
-40,1
-1.13%		-15,8
-15,7
-0.15%
-15,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-14,1
-16,0
12.1%		-11,5
-11,9
3.53%		0,00


-37,7
-37,7
0.05%		5,09
-10,2
149.86%
-0,38

Net income
Million USD		Released
Forecast
Spread 		-14,4
-15,8
9.23%		-11,5
-11,9
3.53%		0,00


-36,6
-37,1
1.39%		5,53
-12,8
143.15%
-0,38

EPS
USD		Released
Forecast
Spread 		-0,82
-0,90
8.89%		-0,56
-0,58
4%		-0,31


-0,94
-0,95
1.26%		0,14
-0,32
144.44%
-0,01

Announcement Date27/11/1924/11/2030/03/2206/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,67
0,70
-4.86%		0,67
0,70
-3.71%		0,68
0,69
-1.52%		0,68
0,71
-4.64%		0,67
0,73
-9.18%		0,67
0,70
-3.71%		0,00
0,70
- 		0,00
0,00
-



0,25


0,25


0,25

EBIT
Million USD		Released
Forecast
Spread 		-11,3
-11,0
-2.29%		-11,4
-9,60
-18.93%		-8,19
-9,57
14.46%		-9,74
-9,98
2.4%		-5,21
-10,9
52.22%		-3,79
-4,67
18.76%		-2,89
-3,85
24.86%		-3,88
-3,85
-0.7%



-3,40


-3,70


-5,60

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,7
-10,8
0.85%		-11,1
-9,50
-16.49%		-7,15
-10,4
31.18%		-8,74
-10,00
12.6%		-3,61
-10,1
64.25%		-1,31
-4,00
67.18%		-3,28
-3,55
7.49%		13,3
-2,00
764.8%



0,40


-0,05


-2,30

Net income
Million USD		Released
Forecast
Spread 		-10,4
-10,8
3.47%		-10,5
-9,50
-10.87%		-7,06
-9,87
28.44%		-8,54
-9,48
9.87%		-3,40
-10,1
66.39%		-1,19
-3,93
69.64%		-3,22
-3,40
5.24%		13,3
-4,80
377.83%		1,54



0,40


-0,05


-2,30

EPS
USD		Released
Forecast
Spread 		-0,27
-0,27
0%		-0,27
-0,25
-10.2%		-0,18
-0,25
28.95%		-0,22
-0,24
7.69%		-0,08
-0,25
67.35%		-0,03
-0,10
70%		-0,08
-0,09
7.7%		0,33
-0,12
375%		0,04



0,01


0,00


-0,06

Announcement Date12/05/2210/08/2210/11/2206/03/2311/05/2310/08/2309/11/2306/03/2409/05/24---

Upcoming sector events for Oramed Pharmaceuticals, Inc.

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Oramed Pharmaceuticals, Inc.

29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
14/05/2024 21:05 KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. Stock
  5. Calendar Oramed Pharmaceuticals, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW